Research On Development Strategy For Shenzhen Kangtai Biological Products Co.,Ltd.

Shenzhen Kangtai Biological Products Corporation Ltd.,mainly specialized in the vaccine sector,integrates R&D,production and marketing of biological products.In the new 21 st century,the vaccine part has been among the most actively growing and the most rapidly developing sectors of the global pharmaceutical industry.Even though its production in terms of volume and its producers in terms of quantity rank the top,China is not a worldly vaccine power while it actually lags far behind the advanced.With vaccine industry being classified as the strategic emerging industry by the Chinese government,it has promulgated a great number of industrial policies to boost the sound development of the industry.Under the environment of increasingly intense competition,Kangtai should formulate a feasible strategy to gain the competitive advantage for the future sustainable growth.This paper analyzes the background of the vaccine industry and expatiates the significance of the research with integration of the status quo market competition.After researching existing papers on development strategy of enterprises home and abroad,this paper proposes its own ways and modes.With the application of PEST model and Porter's Five Forces Model,it systematically analyzes the external environment and the competition of the company,involving aspects of politics,economy,society,and technology.With SWOT method,it analyzes the opportunities and threats under current environment,and the advantages and disadvantages of the company in the vaccine industry.Then it determines the competitive measures and formulates the development strategy and its implications.This paper provides thinking on achieving great-leap-forward development by improving the core competitiveness of Kangtai under the environment of intense competition,which is of great reference significance to domestic vaccine enterprises in formulating development strategy.